University of Pittsburgh
May 20, 2015

Can Psychosocial Treatments Help Autistic Adults?

Multimillion dollar grant will fund study to assess if nondrug therapies improve the quality of life for adults with autism spectrum disorder
Contact: 

Sharon Blake

412-624-4364

Cell: 412-277-6926

PITTSBURGH—A University of Pittsburgh researcher has received a $3.2 million grant from the National Institute of Mental Health to determine whether nondrug psychosocial treatments can improve the quality of life for adults with autism spectrum disorder.

It will be the largest study ever conducted to assess whether cognitive enhancement therapy and enriched supportive therapy can help adults with a complex disorder that influences how a person behaves, learns, communicates, and interacts with others. Currently, autism spectrum disorder affects one out of 68 children in the United States.

The research program—called Perspectives—will take place at Pitt and will be led by Shaun Eack, Pitt's David E. Epperson Associate Professor of Social Work and an associate professor of psychiatry, in collaboration with Nancy Minshew, a professor of psychiatry and neurology in Pitt's School of Medicine and director of the University's Center for Excellence in Autism Research.

The study will include 100 participants, ages 16-40, who will be randomly assigned to one of two psychotherapies for up to 18 months.

The first, cognitive enhancement therapy, involves about three and a half hours a week of computer exercises in attention, memory, and problem solving, along with small group sessions in which the participant learns how to act wisely in social situations by learning to read nonverbal cues, understanding another person's perspective, and other aspects of successful social interaction.

The second, enriched supportive therapy, takes place for about an hour a week and is a one-on-one therapy to help adults learn about their condition, manage their emotions and stress, improve their social skills, and cope with everyday problems.

“The evidence base for treatment for adults with autism is almost nonexistent,” says Eack. “This study will establish whether cognitive enhancement therapy and enriched supportive therapy are effective for treating autism, which is essential for making more treatments available in the community for adults.”

“Ultimately, we hope the study will establish an evidence base for both cognitive enhancement therapy and enriched supportive therapy and also will tell us about the comparative benefits of both interventions in adults, about which we know very little,” he added.

The research team will collect neuroimaging data as well as data from interviews with clinicians and family members to assess if the therapies are working.

It is Eack’s hope that the therapies can also eventually be made available to the many children who have autism spectrum disorder who will continue to need help as they grow into adulthood. His earlier work revealed that cognitive enhancement therapy was very successful in patients with schizophrenia.

“Social work has a long history of developing psychosocial interventions for people with disabilities,” he added. “And we are working closely with Pitt's experts in the Department of Psychiatry. This work could not be done without interdisciplinary collaborations.”

Visit http://www.wpic.pitt.edu/research/CeFAR/ for more information about autism spectrum disorder.

Contact autismrecruiter@upmc.edu or 1-866-647-3436 if interested in participating in the study.

###

5/19/15/klf/cm